{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:48:59Z","timestamp":1791215339453,"version":"4.1.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T00:00:00Z","timestamp":1544140800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Pfizer Lab"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,1]]},"DOI":"10.1093\/jac\/dky489","type":"journal-article","created":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T15:09:54Z","timestamp":1541603394000},"page":"675-681","source":"Crossref","is-referenced-by-count":29,"title":["Cerebrospinal fluid pharmacokinetics of ceftaroline in neurosurgical patients with an external ventricular drain"],"prefix":"10.1093","volume":"74","author":[{"given":"Alexia","family":"Chauzy","sequence":"first","affiliation":[{"name":"Universit\u00e9 de Poitiers, INSERM U1070, CHU Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelouaid","family":"Nadji","sequence":"additional","affiliation":[{"name":"Neuror\u00e9animation, H\u00f4pital du Bocage, CHU Dijon, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Combes","sequence":"additional","affiliation":[{"name":"Neuror\u00e9animation, H\u00f4pital du Bocage, CHU Dijon, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Defrance","sequence":"additional","affiliation":[{"name":"Neuror\u00e9animation, H\u00f4pital du Bocage, CHU Dijon, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belaid","family":"Bouhemad","sequence":"additional","affiliation":[{"name":"Neuror\u00e9animation, H\u00f4pital du Bocage, CHU Dijon, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Couet","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Poitiers, INSERM U1070, CHU Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Chavanet","sequence":"additional","affiliation":[{"name":"D\u00e9partement d\u2019Infectiologie, CHU and INSERM CIC1432, Universit\u00e9 de Bourgogne, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,12,6]]},"reference":[{"key":"key\n\t\t\t\t2019021507301894700_dky489-B1","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/cid\/cir147","article-title":"Ceftaroline: a novel cephalosporin with activity against methicillin-resistant Staphylococcus aureus","volume":"52","author":"Saravolatz","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B2","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1128\/AAC.02436-12","article-title":"Antimicrobial activity of ceftaroline-avibactam tested against clinical isolates collected from U.S. Medical Centers in 2010\u20132011","volume":"57","author":"Sader","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B3","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1345\/aph.1Q225","article-title":"Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus","volume":"45","author":"Jorgenson","year":"2011","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B4","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1128\/AAC.00484-13","article-title":"Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011","volume":"57","author":"Sader","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/AAC.01516-13","article-title":"In vitro pharmacodynamics of human simulated exposures of ceftaroline and daptomycin against MRSA, hVISA, and VISA with and without prior vancomycin exposure","volume":"58","author":"Bhalodi","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B6","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1128\/AAC.01915-13","article-title":"Activities of vancomycin, ceftaroline, and mupirocin against Staphylococcus aureus isolates collected in a 2011 National Surveillance Study in the United States","volume":"58","author":"Richter","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B7","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/AAC.00330-12","article-title":"Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance program","volume":"56","author":"Flamm","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B8","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/cid\/ciw861","article-title":"2017 Infectious Diseases Society of America\u2019s clinical practice guidelines for healthcare-associated ventriculitis and meningitis","volume":"64","author":"Tunkel","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12879-014-0712-z","article-title":"A meta-analysis of ventriculostomy-associated cerebrospinal fluid infections","volume":"15","author":"Ramanan","year":"2015","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jnnp-2017-316415","article-title":"Prospective, multicentre study of external ventricular drainage-related infections in the UK and Ireland","volume":"89","author":"Jamjoom","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/sur.2014.098","article-title":"A pharmacokinetic\/pharmacodynamic analysis of ceftaroline prophylaxis in patients with external ventricular drains","volume":"16","author":"Stein","year":"2015","journal-title":"Surg Infect (Larchmt)"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B12","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/jac\/dku464","article-title":"Ceftaroline CSF concentrations in a patient with ventriculoperitoneal shunt-related meningitis","volume":"70","author":"Kuriakose","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B13","author":"Beal","year":"2017"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-2607(98)00067-4","article-title":"Xpose\u2014an S-PLUS based population pharmacokinetic\/pharmacodynamic model building aid for NONMEM","volume":"58","author":"Jonsson","year":"1999","journal-title":"Comput Methods Programs Biomed"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B15","doi-asserted-by":"crossref","first-page":"iv33","DOI":"10.1093\/jac\/dkq253","article-title":"Pharmacodynamics of ceftaroline fosamil for complicated skin and skin structure infection: rationale for improved anti-methicillin-resistant Staphylococcus aureus activity","volume":"65","author":"Drusano","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B16","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/jcph.153","article-title":"Population pharmacokinetics of ceftaroline in patients with acute bacterial skin and skin structure infections or community-acquired bacterial pneumonia","volume":"53","author":"Van Wart","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B17","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/jcph.265","article-title":"A series of pharmacokinetic studies of ceftaroline fosamil in select populations: normal subjects, healthy elderly subjects, and subjects with renal impairment or end-stage renal disease requiring hemodialysis","volume":"54","author":"Riccobene","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B18","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1002\/sim.5515","article-title":"The ghosts of departed quantities: approaches to dealing with observations below the limit of quantitation","volume":"31","author":"Senn","year":"2012","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1012299115260","article-title":"Ways to fit a PK model with some data below the quantification limit","volume":"28","author":"Beal","year":"2001","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","article-title":"PsN-Toolkit\u2014a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM","volume":"79","author":"Lindbom","year":"2005","journal-title":"Comput Methods Programs Biomed"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/ene.13513","article-title":"Cerebrospinal fluid: serum glucose ratio in the ventricular and lumbar compartments: implications for clinical practice","volume":"25","author":"Hegen","year":"2018","journal-title":"Eur J Neurol"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ajem.2013.11.030","article-title":"Cerebrospinal fluid\/blood glucose ratio as an indicator for bacterial meningitis","volume":"32","author":"Tamune","year":"2014","journal-title":"Am J Emerg Med"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.diagmicrobio.2012.02.010","article-title":"The utility of cerebrospinal fluid parameters in the early microbiological assessment of meningitis","volume":"73","author":"White","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10928-013-9301-9","article-title":"Utility of CSF in translational neuroscience","volume":"40","author":"de Lange","year":"2013","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B25","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1128\/AAC.00097-16","article-title":"Single- and repeated-dose pharmacokinetics of ceftaroline in plasma and soft tissues of healthy volunteers for two different dosing regimens of ceftaroline fosamil","volume":"60","author":"Matzneller","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ccc.2006.02.011","article-title":"Pharmacokinetic changes in critical illness","volume":"22","author":"Boucher","year":"2006","journal-title":"Crit Care Clin"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B27","year":"2017"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijantimicag.2013.08.019","article-title":"Continuous versus intermittent infusion of cefepime in neurosurgical patients with post-operative intracranial infections","volume":"43","author":"Huang","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B29","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/jcph.317","article-title":"Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis","volume":"54","author":"Zhao","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B30","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ijantimicag.2005.08.005","article-title":"Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children","volume":"26","author":"Goldwater","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B31","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1128\/AAC.37.7.1518","article-title":"Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges","volume":"37","author":"Nau","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B32","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/AAC.02570-12","article-title":"Microdialysis study of cefotaxime cerebral distribution in patients with acute brain injury","volume":"57","author":"Dahyot-Fizelier","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B33","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/AAC.39.1.253","article-title":"Cerebrospinal fluid penetration of amikacin in children with community-acquired bacterial meningitis","volume":"39","author":"Gaillard","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B34","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5114\/aoms.2016.59269","article-title":"Usefulness of inflammatory biomarkers in discriminating between bacterial and aseptic meningitis in hospitalized children from a population with low vaccination coverage","volume":"12","author":"Gowin","year":"2016","journal-title":"Arch Med Sci"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1473-3099(15)00430-2","article-title":"Community-acquired bacterial meningitis in adults in the Netherlands, 2006\u201314: a prospective cohort study","volume":"16","author":"Bijlsma","year":"2016","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B36","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/S0140-6736(12)61185-4","article-title":"Dilemmas in the diagnosis of acute community-acquired bacterial meningitis","volume":"380","author":"Brouwer","year":"2012","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.eimc.2015.03.004","article-title":"Clinical, biochemical and microbiological factors associated with the prognosis of pneumococcal meningitis in children","volume":"34","author":"Jordan","year":"2016","journal-title":"Enferm Infecc Microbiol Cl\u00edn"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B38","first-page":"28","article-title":"Mortality in pneumococcal meningitis: a multivariate analysis of prognostic factors","volume":"2","author":"Hoen","year":"1993","journal-title":"Eur J Med"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0006-8993(98)00423-5","article-title":"Effect of induced hyperglycemia on brain cell membrane function and energy metabolism during the early phase of experimental meningitis in newborn piglets","volume":"798","author":"Park","year":"1998","journal-title":"Brain Res"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0163-4453(81)80003-5","article-title":"Pathophysiological correlates in bacterial meningitis","volume":"3","author":"Scheld","year":"1981","journal-title":"J Infect"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/exnr.1997.6458","article-title":"Blood\u2013brain barrier permeability during the development of experimental bacterial meningitis in the rat","volume":"145","author":"Kim","year":"1997","journal-title":"Exp Neurol"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF02630996","article-title":"Blood\u2013brain barrier alterations in bacterial meningitis: development of an in vitro model and observations on the effects of lipopolysaccharide","volume":"27A","author":"Tunkel","year":"1991","journal-title":"In Vitro Cell Dev Biol"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B43","doi-asserted-by":"crossref","first-page":"13529","DOI":"10.1038\/s41598-017-13234-1","article-title":"Quantitative assessment of the blood\u2013brain barrier opening caused by Streptococcus agalactiae hyaluronidase in a BALB\/c mouse model","volume":"7","author":"Luo","year":"2017","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/QCO.0000000000000418","article-title":"Pharmacokinetics and pharmacodynamics of antibiotics in central nervous system infections","volume":"31","author":"Nau","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B45","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10096-017-3171-9","article-title":"Coagulase-negative staphylococci are associated to the mild inflammatory pattern of healthcare-associated meningitis: a retrospective study","volume":"37","author":"Couffin","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t2019021507301894700_dky489-B46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinf.2016.09.007","article-title":"Adults with suspected central nervous system infection: a prospective study of diagnostic accuracy","volume":"74","author":"Khatib","year":"2017","journal-title":"J Infect"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/3\/675\/27785331\/dky489.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T01:07:59Z","timestamp":1720746479000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/74\/3\/675\/5232578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,6]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,12,6]]},"published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky489","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3]]},"published":{"date-parts":[[2018,12,6]]}}}